Skip to content

Effect of Teriadent and Ora-Aid in teratment of minor aphthous ulcer

Comparison of the effect of teriadent and Ora-Aid mucosal adhesive in patients with minor aphthous ulcer

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210306050606N1
Enrollment
40
Registered
2021-09-13
Start date
2021-08-15
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minor Aphthous Ulcer.

Interventions

Intervention group:Triamcinolone acetonide adhesive 0.1% made by Raha Pharmaceutical Company will be used for 20 patients. Triamcinolone acetonide is a moderate to severe corticosteroid and a derivati

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: The patient must be 20 to 40 years old Onset of the aphthous ulcers must not be more than one day No treatment must be applied for the aphthous lesions before visiting the school Patients must agree to participate and cooperate in this research Patients must not suffer from known systemic diseases associated with aphthous ulcers and they must not have suspected symptoms of systemic diseases associated with aphthous ulcers Lesions must be in the tonsils and 1.3 posterior of the mouth

Exclusion criteria

Exclusion criteria: Using another drug at the same time as the prescribed drug to treat the pest Not using the drug as recommended according to the patient's statements Not attending the School for re-examination Having symptoms of Behcet's disease (recurrent aphthous ulcers, recurrent genital lesions, skin and eye lesions)

Design outcomes

Primary

MeasureTime frame
The size of the lesion. Timepoint: Measurement of aphthous ulcer diameter at the beginning of the study and 3, 5 and 7 days after use of Teriadent and Ora-Aid Mucosal Adhesive. Method of measurement: The size of the lesion will be measured based on the maximum wound diameter using one-millimeter checkered paper.

Secondary

MeasureTime frame
Pain and irritation intensity. Timepoint: Measurement of pain and irritation intensity at the beginning of the study and 3, 5 and 7 days after use of Teriadent and Ora-Aid Mucosal Adhesive. Method of measurement: The patient's pain and irritation intensity will be measured according to the Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAdeleh Pouyafard

Yazd University of Medical Sciences

hamidrezagh776@gmail.com+98 35 3621 3871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026